TrialThe Journal of clinical endocrinology and metabolism2015

Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.

Zhidong Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.